id	sid	tid	token	lemma	pos
kk91fj26b0m	1	1	antibiotic	antibiotic	ADJ
kk91fj26b0m	1	2	resistance	resistance	NOUN
kk91fj26b0m	1	3	has	have	AUX
kk91fj26b0m	1	4	significantly	significantly	ADV
kk91fj26b0m	1	5	increased	increase	VERB
kk91fj26b0m	1	6	since	since	SCONJ
kk91fj26b0m	1	7	the	the	DET
kk91fj26b0m	1	8	beginning	beginning	NOUN
kk91fj26b0m	1	9	of	of	ADP
kk91fj26b0m	1	10	the	the	DET
kk91fj26b0m	1	11	21st	21st	ADJ
kk91fj26b0m	1	12	century	century	NOUN
kk91fj26b0m	1	13	.	.	PUNCT
kk91fj26b0m	2	1	currently	currently	ADV
kk91fj26b0m	2	2	,	,	PUNCT
kk91fj26b0m	2	3	the	the	DET
kk91fj26b0m	2	4	polymyxin	polymyxin	ADJ
kk91fj26b0m	2	5	colistin	colistin	NOUN
kk91fj26b0m	2	6	is	be	AUX
kk91fj26b0m	2	7	typically	typically	ADV
kk91fj26b0m	2	8	viewed	view	VERB
kk91fj26b0m	2	9	as	as	ADP
kk91fj26b0m	2	10	the	the	DET
kk91fj26b0m	2	11	antibiotic	antibiotic	NOUN
kk91fj26b0m	2	12	of	of	ADP
kk91fj26b0m	2	13	last	last	ADJ
kk91fj26b0m	2	14	resort	resort	NOUN
kk91fj26b0m	2	15	for	for	ADP
kk91fj26b0m	2	16	the	the	DET
kk91fj26b0m	2	17	treatment	treatment	NOUN
kk91fj26b0m	2	18	of	of	ADP
kk91fj26b0m	2	19	multidrug	multidrug	NOUN
kk91fj26b0m	2	20	resistant	resistant	ADJ
kk91fj26b0m	2	21	gram	gram	ADJ
kk91fj26b0m	2	22	-	-	PUNCT
kk91fj26b0m	2	23	negative	negative	ADJ
kk91fj26b0m	2	24	bacterial	bacterial	ADJ
kk91fj26b0m	2	25	infections.however	infections.however	NOUN
kk91fj26b0m	2	26	,	,	PUNCT
kk91fj26b0m	2	27	even	even	ADV
kk91fj26b0m	2	28	with	with	ADP
kk91fj26b0m	2	29	the	the	DET
kk91fj26b0m	2	30	clinician	clinician	NOUN
kk91fj26b0m	2	31	's	's	PART
kk91fj26b0m	2	32	knowledge	knowledge	NOUN
kk91fj26b0m	2	33	of	of	ADP
kk91fj26b0m	2	34	nephrotoxicity	nephrotoxicity	NOUN
kk91fj26b0m	2	35	to	to	ADP
kk91fj26b0m	2	36	the	the	DET
kk91fj26b0m	2	37	patient	patient	NOUN
kk91fj26b0m	2	38	,	,	PUNCT
kk91fj26b0m	2	39	colistin	colistin	PROPN
kk91fj26b0m	2	40	usage	usage	NOUN
kk91fj26b0m	2	41	has	have	AUX
kk91fj26b0m	2	42	increased	increase	VERB
kk91fj26b0m	2	43	.	.	PUNCT
kk91fj26b0m	3	1	consequently	consequently	ADV
kk91fj26b0m	3	2	,	,	PUNCT
kk91fj26b0m	3	3	it	it	PRON
kk91fj26b0m	3	4	has	have	AUX
kk91fj26b0m	3	5	also	also	ADV
kk91fj26b0m	3	6	resulted	result	VERB
kk91fj26b0m	3	7	in	in	ADP
kk91fj26b0m	3	8	colistin	colistin	PROPN
kk91fj26b0m	3	9	resistant	resistant	ADJ
kk91fj26b0m	3	10	bacterial	bacterial	ADJ
kk91fj26b0m	3	11	isolates	isolate	NOUN
kk91fj26b0m	3	12	becoming	become	VERB
kk91fj26b0m	3	13	more	more	ADV
kk91fj26b0m	3	14	common	common	ADJ
kk91fj26b0m	3	15	.	.	PUNCT
kk91fj26b0m	4	1	the	the	DET
kk91fj26b0m	4	2	recent	recent	ADJ
kk91fj26b0m	4	3	dissemination	dissemination	NOUN
kk91fj26b0m	4	4	of	of	ADP
kk91fj26b0m	4	5	plasmid	plasmid	ADJ
kk91fj26b0m	4	6	-	-	PUNCT
kk91fj26b0m	4	7	borne	bear	VERB
kk91fj26b0m	4	8	colistin	colistin	PROPN
kk91fj26b0m	4	9	resistance	resistance	PROPN
kk91fj26b0m	4	10	genes	gene	NOUN
kk91fj26b0m	4	11	(	(	PUNCT
kk91fj26b0m	4	12	mcr	mcr	ADJ
kk91fj26b0m	4	13	1	1	NUM
kk91fj26b0m	4	14	-	-	SYM
kk91fj26b0m	4	15	8)	8)	NUM
kk91fj26b0m	4	16	into	into	ADP
kk91fj26b0m	4	17	the	the	DET
kk91fj26b0m	4	18	human	human	ADJ
kk91fj26b0m	4	19	pathogen	pathogen	PROPN
kk91fj26b0m	4	20	pool	pool	NOUN
kk91fj26b0m	4	21	is	be	AUX
kk91fj26b0m	4	22	further	far	ADV
kk91fj26b0m	4	23	threatening	threaten	VERB
kk91fj26b0m	4	24	to	to	PART
kk91fj26b0m	4	25	render	render	VERB
kk91fj26b0m	4	26	colistin	colistin	PROPN
kk91fj26b0m	4	27	therapy	therapy	PROPN
kk91fj26b0m	4	28	ineffective	ineffective	ADJ
kk91fj26b0m	4	29	.	.	PUNCT
kk91fj26b0m	5	1	new	new	ADJ
kk91fj26b0m	5	2	methods	method	NOUN
kk91fj26b0m	5	3	to	to	PART
kk91fj26b0m	5	4	combat	combat	VERB
kk91fj26b0m	5	5	antibiotic	antibiotic	ADJ
kk91fj26b0m	5	6	resistant	resistant	ADJ
kk91fj26b0m	5	7	pathogens	pathogen	NOUN
kk91fj26b0m	5	8	are	be	AUX
kk91fj26b0m	5	9	needed	need	VERB
kk91fj26b0m	5	10	.	.	PUNCT
kk91fj26b0m	6	1	herein	herein	ADV
kk91fj26b0m	6	2	the	the	DET
kk91fj26b0m	6	3	utilization	utilization	NOUN
kk91fj26b0m	6	4	of	of	ADP
kk91fj26b0m	6	5	a	a	DET
kk91fj26b0m	6	6	colistin	colistin	NOUN
kk91fj26b0m	6	7	-	-	PUNCT
kk91fj26b0m	6	8	adjuvant	adjuvant	NOUN
kk91fj26b0m	6	9	combination	combination	NOUN
kk91fj26b0m	6	10	,	,	PUNCT
kk91fj26b0m	6	11	where	where	SCONJ
kk91fj26b0m	6	12	the	the	DET
kk91fj26b0m	6	13	adjuvant	adjuvant	NOUN
kk91fj26b0m	6	14	is	be	AUX
kk91fj26b0m	6	15	non	non	ADJ
kk91fj26b0m	6	16	-	-	ADJ
kk91fj26b0m	6	17	toxic	toxic	ADJ
kk91fj26b0m	6	18	to	to	ADP
kk91fj26b0m	6	19	the	the	DET
kk91fj26b0m	6	20	bacteria	bacteria	NOUN
kk91fj26b0m	6	21	alone	alone	ADV
kk91fj26b0m	6	22	,	,	PUNCT
kk91fj26b0m	6	23	is	be	AUX
kk91fj26b0m	6	24	effective	effective	ADJ
kk91fj26b0m	6	25	in	in	ADP
kk91fj26b0m	6	26	potentiating	potentiating	PROPN
kk91fj26b0m	6	27	colistin	colistin	PROPN
kk91fj26b0m	6	28	against	against	ADP
kk91fj26b0m	6	29	gram	gram	ADJ
kk91fj26b0m	6	30	-	-	PUNCT
kk91fj26b0m	6	31	negative	negative	ADJ
kk91fj26b0m	6	32	bacteria	bacteria	NOUN
kk91fj26b0m	6	33	in	in	ADP
kk91fj26b0m	6	34	hopes	hope	NOUN
kk91fj26b0m	6	35	of	of	ADP
kk91fj26b0m	6	36	lowering	lower	VERB
kk91fj26b0m	6	37	toxic	toxic	ADJ
kk91fj26b0m	6	38	effects	effect	NOUN
kk91fj26b0m	6	39	to	to	ADP
kk91fj26b0m	6	40	the	the	DET
kk91fj26b0m	6	41	patient	patient	NOUN
kk91fj26b0m	6	42	.	.	PUNCT
kk91fj26b0m	7	1	against	against	ADP
kk91fj26b0m	7	2	colistin	colistin	PROPN
kk91fj26b0m	7	3	sensitive	sensitive	PROPN
kk91fj26b0m	7	4	bacteria	bacteria	NOUN
kk91fj26b0m	7	5	,	,	PUNCT
kk91fj26b0m	7	6	a	a	DET
kk91fj26b0m	7	7	2	2	NUM
kk91fj26b0m	7	8	-	-	PUNCT
kk91fj26b0m	7	9	aminoimidazole	aminoimidazole	NOUN
kk91fj26b0m	7	10	adjuvant	adjuvant	NOUN
kk91fj26b0m	7	11	enabled	enable	VERB
kk91fj26b0m	7	12	a	a	DET
kk91fj26b0m	7	13	1000	1000	NUM
kk91fj26b0m	7	14	-	-	ADJ
kk91fj26b0m	7	15	fold	fold	ADJ
kk91fj26b0m	7	16	reduction	reduction	NOUN
kk91fj26b0m	7	17	in	in	ADP
kk91fj26b0m	7	18	the	the	DET
kk91fj26b0m	7	19	minimum	minimum	ADJ
kk91fj26b0m	7	20	inhibitory	inhibitory	ADJ
kk91fj26b0m	7	21	concentration	concentration	NOUN
kk91fj26b0m	7	22	(	(	PUNCT
kk91fj26b0m	7	23	mic	mic	NOUN
kk91fj26b0m	7	24	)	)	PUNCT
kk91fj26b0m	7	25	of	of	ADP
kk91fj26b0m	7	26	colistin	colistin	PROPN
kk91fj26b0m	7	27	in	in	ADP
kk91fj26b0m	7	28	vitro	vitro	PROPN
kk91fj26b0m	7	29	when	when	SCONJ
kk91fj26b0m	7	30	tested	test	VERB
kk91fj26b0m	7	31	at	at	ADP
kk91fj26b0m	7	32	a	a	DET
kk91fj26b0m	7	33	concentration	concentration	NOUN
kk91fj26b0m	7	34	of	of	ADP
kk91fj26b0m	7	35	30	30	NUM
kk91fj26b0m	7	36	µm	µm	NOUN
kk91fj26b0m	7	37	and	and	CCONJ
kk91fj26b0m	7	38	at	at	ADP
kk91fj26b0m	7	39	15	15	NUM
kk91fj26b0m	7	40	µm	µm	NOUN
kk91fj26b0m	7	41	,	,	PUNCT
kk91fj26b0m	7	42	it	it	PRON
kk91fj26b0m	7	43	reduced	reduce	VERB
kk91fj26b0m	7	44	the	the	DET
kk91fj26b0m	7	45	colistin	colistin	PROPN
kk91fj26b0m	7	46	mic	mic	NOUN
kk91fj26b0m	7	47	against	against	ADP
kk91fj26b0m	7	48	three	three	NUM
kk91fj26b0m	7	49	colistin	colistin	PROPN
kk91fj26b0m	7	50	sensitive	sensitive	PROPN
kk91fj26b0m	7	51	,	,	PUNCT
kk91fj26b0m	7	52	multidrug	multidrug	NOUN
kk91fj26b0m	7	53	resistant	resistant	ADJ
kk91fj26b0m	7	54	acinteobacter	acinteobacter	NOUN
kk91fj26b0m	7	55	baumannii	baumannii	NOUN
kk91fj26b0m	7	56	strains	strain	NOUN
kk91fj26b0m	7	57	from	from	ADP
kk91fj26b0m	7	58	1000	1000	NUM
kk91fj26b0m	7	59	to	to	ADP
kk91fj26b0m	7	60	7.8	7.8	NUM
kk91fj26b0m	7	61	,	,	PUNCT
kk91fj26b0m	7	62	3.9	3.9	NUM
kk91fj26b0m	7	63	,	,	PUNCT
kk91fj26b0m	7	64	and	and	CCONJ
kk91fj26b0m	7	65	3.9	3.9	NUM
kk91fj26b0m	7	66	ng	ng	PROPN
kk91fj26b0m	7	67	/	/	SYM
kk91fj26b0m	7	68	ml	ml	PROPN
kk91fj26b0m	7	69	.	.	PUNCT
kk91fj26b0m	8	1	in	in	ADP
kk91fj26b0m	8	2	an	an	DET
kk91fj26b0m	8	3	additional	additional	ADJ
kk91fj26b0m	8	4	study	study	NOUN
kk91fj26b0m	8	5	,	,	PUNCT
kk91fj26b0m	8	6	an	an	DET
kk91fj26b0m	8	7	indole	indole	NOUN
kk91fj26b0m	8	8	derived	derive	VERB
kk91fj26b0m	8	9	lead	lead	NOUN
kk91fj26b0m	8	10	adjuvant	adjuvant	NOUN
kk91fj26b0m	8	11	increased	increase	VERB
kk91fj26b0m	8	12	colistin	colistin	PROPN
kk91fj26b0m	8	13	efficacy	efficacy	NOUN
kk91fj26b0m	8	14	32	32	NUM
kk91fj26b0m	8	15	-	-	VERB
kk91fj26b0m	8	16	fold	fold	VERB
kk91fj26b0m	8	17	against	against	ADP
kk91fj26b0m	8	18	a	a	DET
kk91fj26b0m	8	19	colistin	colistin	NOUN
kk91fj26b0m	8	20	resistant	resistant	ADJ
kk91fj26b0m	8	21	bacteria	bacteria	NOUN
kk91fj26b0m	8	22	strain	strain	NOUN
kk91fj26b0m	8	23	containing	contain	VERB
kk91fj26b0m	8	24	the	the	DET
kk91fj26b0m	8	25	mcr-1	mcr-1	PUNCT
kk91fj26b0m	8	26	gene	gene	NOUN
kk91fj26b0m	8	27	at	at	ADP
kk91fj26b0m	8	28	5	5	NUM
kk91fj26b0m	8	29	µm	µm	NOUN
kk91fj26b0m	8	30	,	,	PUNCT
kk91fj26b0m	8	31	and	and	CCONJ
kk91fj26b0m	8	32	effects	effect	NOUN
kk91fj26b0m	8	33	a	a	DET
kk91fj26b0m	8	34	1024	1024	NUM
kk91fj26b0m	8	35	-	-	ADJ
kk91fj26b0m	8	36	fold	fold	ADJ
kk91fj26b0m	8	37	increase	increase	NOUN
kk91fj26b0m	8	38	in	in	ADP
kk91fj26b0m	8	39	colistin	colistin	PROPN
kk91fj26b0m	8	40	efficacy	efficacy	NOUN
kk91fj26b0m	8	41	against	against	ADP
kk91fj26b0m	8	42	bacteria	bacteria	NOUN
kk91fj26b0m	8	43	harboring	harbor	VERB
kk91fj26b0m	8	44	chromosomally	chromosomally	ADV
kk91fj26b0m	8	45	encoded	encode	VERB
kk91fj26b0m	8	46	colistin	colistin	PROPN
kk91fj26b0m	8	47	resistance	resistance	PROPN
kk91fj26b0m	8	48	determinants	determinant	NOUN
kk91fj26b0m	8	49	;	;	PUNCT
kk91fj26b0m	8	50	these	these	DET
kk91fj26b0m	8	51	combinations	combination	NOUN
kk91fj26b0m	8	52	lowered	lower	VERB
kk91fj26b0m	8	53	the	the	DET
kk91fj26b0m	8	54	colistin	colistin	PROPN
kk91fj26b0m	8	55	mic	mic	NOUN
kk91fj26b0m	8	56	to	to	ADP
kk91fj26b0m	8	57	levels	level	NOUN
kk91fj26b0m	8	58	at	at	ADP
kk91fj26b0m	8	59	or	or	CCONJ
kk91fj26b0m	8	60	below	below	ADP
kk91fj26b0m	8	61	clinical	clinical	ADJ
kk91fj26b0m	8	62	breakpoint	breakpoint	NOUN
kk91fj26b0m	8	63	levels	level	NOUN
kk91fj26b0m	8	64	for	for	ADP
kk91fj26b0m	8	65	colistin	colistin	PROPN
kk91fj26b0m	8	66	susceptibility	susceptibility	PROPN
kk91fj26b0m	8	67	(	(	PUNCT
kk91fj26b0m	8	68	≤2	≤2	NUM
kk91fj26b0m	8	69	µg	µg	PROPN
kk91fj26b0m	8	70	/	/	SYM
kk91fj26b0m	8	71	ml).in	ml).in	ADJ
kk91fj26b0m	8	72	addition	addition	NOUN
kk91fj26b0m	8	73	to	to	ADP
kk91fj26b0m	8	74	in	in	ADP
kk91fj26b0m	8	75	vitro	vitro	X
kk91fj26b0m	8	76	studies	study	NOUN
kk91fj26b0m	8	77	,	,	PUNCT
kk91fj26b0m	8	78	the	the	DET
kk91fj26b0m	8	79	wax	wax	NOUN
kk91fj26b0m	8	80	worm	worm	PROPN
kk91fj26b0m	8	81	galleria	galleria	PROPN
kk91fj26b0m	8	82	mellonella	mellonella	PROPN
kk91fj26b0m	8	83	provides	provide	VERB
kk91fj26b0m	8	84	an	an	PRON
kk91fj26b0m	8	85	in	in	ADP
kk91fj26b0m	8	86	vivo	vivo	ADJ
kk91fj26b0m	8	87	model	model	NOUN
kk91fj26b0m	8	88	that	that	PRON
kk91fj26b0m	8	89	provides	provide	VERB
kk91fj26b0m	8	90	an	an	DET
kk91fj26b0m	8	91	alternative	alternative	NOUN
kk91fj26b0m	8	92	to	to	ADP
kk91fj26b0m	8	93	expensive	expensive	ADJ
kk91fj26b0m	8	94	and	and	CCONJ
kk91fj26b0m	8	95	ethically	ethically	ADV
kk91fj26b0m	8	96	challenged	challenge	VERB
kk91fj26b0m	8	97	murine	murine	NOUN
kk91fj26b0m	8	98	models	model	NOUN
kk91fj26b0m	8	99	.	.	PUNCT
kk91fj26b0m	9	1	these	these	DET
kk91fj26b0m	9	2	studies	study	NOUN
kk91fj26b0m	9	3	provided	provide	VERB
kk91fj26b0m	9	4	here	here	ADV
kk91fj26b0m	9	5	forth	forth	ADV
kk91fj26b0m	9	6	show	show	VERB
kk91fj26b0m	9	7	the	the	DET
kk91fj26b0m	9	8	process	process	NOUN
kk91fj26b0m	9	9	from	from	ADP
kk91fj26b0m	9	10	start	start	NOUN
kk91fj26b0m	9	11	to	to	ADP
kk91fj26b0m	9	12	finish	finish	VERB
kk91fj26b0m	9	13	in	in	ADP
kk91fj26b0m	9	14	developing	develop	VERB
kk91fj26b0m	9	15	such	such	DET
kk91fj26b0m	9	16	an	an	DET
kk91fj26b0m	9	17	assay	assay	NOUN
kk91fj26b0m	9	18	,	,	PUNCT
kk91fj26b0m	9	19	starting	start	VERB
kk91fj26b0m	9	20	with	with	ADP
kk91fj26b0m	9	21	bacterial	bacterial	ADJ
kk91fj26b0m	9	22	virulence	virulence	NOUN
kk91fj26b0m	9	23	within	within	ADP
kk91fj26b0m	9	24	the	the	DET
kk91fj26b0m	9	25	worms	worm	NOUN
kk91fj26b0m	9	26	.	.	PUNCT
kk91fj26b0m	10	1	furthermore	furthermore	ADV
kk91fj26b0m	10	2	,	,	PUNCT
kk91fj26b0m	10	3	a	a	DET
kk91fj26b0m	10	4	narrow	narrow	ADJ
kk91fj26b0m	10	5	-	-	PUNCT
kk91fj26b0m	10	6	spectrum	spectrum	NOUN
kk91fj26b0m	10	7	antibiotic	antibiotic	ADJ
kk91fj26b0m	10	8	synthesized	synthesize	VERB
kk91fj26b0m	10	9	within	within	ADP
kk91fj26b0m	10	10	our	our	PRON
kk91fj26b0m	10	11	lab	lab	NOUN
kk91fj26b0m	10	12	showed	show	VERB
kk91fj26b0m	10	13	increased	increase	VERB
kk91fj26b0m	10	14	worm	worm	NOUN
kk91fj26b0m	10	15	survival	survival	NOUN
kk91fj26b0m	10	16	against	against	ADP
kk91fj26b0m	10	17	a	a	DET
kk91fj26b0m	10	18	multidrug	multidrug	NOUN
kk91fj26b0m	10	19	resistant	resistant	ADJ
kk91fj26b0m	10	20	a.	a.	NOUN
kk91fj26b0m	10	21	baumannii	baumannii	ADJ
kk91fj26b0m	10	22	strain	strain	NOUN
kk91fj26b0m	10	23	;	;	PUNCT
kk91fj26b0m	10	24	tested	test	VERB
kk91fj26b0m	10	25	at	at	ADP
kk91fj26b0m	10	26	50	50	NUM
kk91fj26b0m	10	27	mg	mg	NOUN
kk91fj26b0m	10	28	/	/	SYM
kk91fj26b0m	10	29	kg	kg	NOUN
kk91fj26b0m	10	30	and	and	CCONJ
kk91fj26b0m	10	31	100	100	NUM
kk91fj26b0m	10	32	mg	mg	NOUN
kk91fj26b0m	10	33	/	/	SYM
kk91fj26b0m	10	34	kg	kg	NOUN
kk91fj26b0m	10	35	,	,	PUNCT
kk91fj26b0m	10	36	worm	worm	NOUN
kk91fj26b0m	10	37	survival	survival	NOUN
kk91fj26b0m	10	38	was	be	AUX
kk91fj26b0m	10	39	22	22	NUM
kk91fj26b0m	10	40	%	%	NOUN
kk91fj26b0m	10	41	and	and	CCONJ
kk91fj26b0m	10	42	32	32	NUM
kk91fj26b0m	10	43	%	%	NOUN
kk91fj26b0m	10	44	after	after	ADP
kk91fj26b0m	10	45	a	a	DET
kk91fj26b0m	10	46	six	six	NUM
kk91fj26b0m	10	47	-	-	PUNCT
kk91fj26b0m	10	48	day	day	NOUN
kk91fj26b0m	10	49	study	study	NOUN
kk91fj26b0m	10	50	,	,	PUNCT
kk91fj26b0m	10	51	respectively	respectively	ADV
kk91fj26b0m	10	52	.	.	PUNCT
kk91fj26b0m	11	1	this	this	DET
kk91fj26b0m	11	2	model	model	NOUN
kk91fj26b0m	11	3	has	have	AUX
kk91fj26b0m	11	4	expanded	expand	VERB
kk91fj26b0m	11	5	to	to	PART
kk91fj26b0m	11	6	include	include	VERB
kk91fj26b0m	11	7	antibiotic	antibiotic	ADJ
kk91fj26b0m	11	8	-	-	PUNCT
kk91fj26b0m	11	9	adjuvant	adjuvant	ADJ
kk91fj26b0m	11	10	combinations	combination	NOUN
kk91fj26b0m	11	11	to	to	PART
kk91fj26b0m	11	12	battle	battle	NOUN
kk91fj26b0m	11	13	multidrug	multidrug	NOUN
kk91fj26b0m	11	14	resistant	resistant	ADJ
kk91fj26b0m	11	15	bacteria	bacteria	NOUN
kk91fj26b0m	11	16	.	.	PUNCT
kk91fj26b0m	12	1	antibiotic	antibiotic	ADJ
kk91fj26b0m	12	2	-	-	PUNCT
kk91fj26b0m	12	3	adjuvant	adjuvant	ADJ
kk91fj26b0m	12	4	concentrations	concentration	NOUN
kk91fj26b0m	12	5	,	,	PUNCT
kk91fj26b0m	12	6	where	where	SCONJ
kk91fj26b0m	12	7	the	the	DET
kk91fj26b0m	12	8	adjuvant	adjuvant	NOUN
kk91fj26b0m	12	9	is	be	AUX
kk91fj26b0m	12	10	tested	test	VERB
kk91fj26b0m	12	11	at	at	ADP
kk91fj26b0m	12	12	50	50	NUM
kk91fj26b0m	12	13	mg	mg	NOUN
kk91fj26b0m	12	14	/	/	SYM
kk91fj26b0m	12	15	kg	kg	NOUN
kk91fj26b0m	12	16	or	or	CCONJ
kk91fj26b0m	12	17	100	100	NUM
kk91fj26b0m	12	18	mg	mg	NOUN
kk91fj26b0m	12	19	/	/	SYM
kk91fj26b0m	12	20	kg	kg	NOUN
kk91fj26b0m	12	21	in	in	ADP
kk91fj26b0m	12	22	combination	combination	NOUN
kk91fj26b0m	12	23	with	with	ADP
kk91fj26b0m	12	24	an	an	DET
kk91fj26b0m	12	25	antibiotic	antibiotic	ADJ
kk91fj26b0m	12	26	,	,	PUNCT
kk91fj26b0m	12	27	have	have	AUX
kk91fj26b0m	12	28	increased	increase	VERB
kk91fj26b0m	12	29	survival	survival	NOUN
kk91fj26b0m	12	30	of	of	ADP
kk91fj26b0m	12	31	inoculated	inoculated	ADJ
kk91fj26b0m	12	32	worms	worm	NOUN
kk91fj26b0m	12	33	up	up	ADP
kk91fj26b0m	12	34	to	to	PART
kk91fj26b0m	12	35	50	50	NUM
kk91fj26b0m	12	36	%	%	NOUN
kk91fj26b0m	12	37	over	over	ADP
kk91fj26b0m	12	38	the	the	DET
kk91fj26b0m	12	39	course	course	NOUN
kk91fj26b0m	12	40	of	of	ADP
kk91fj26b0m	12	41	several	several	ADJ
kk91fj26b0m	12	42	days	day	NOUN
kk91fj26b0m	12	43	.	.	PUNCT
kk91fj26b0m	13	1	two	two	NUM
kk91fj26b0m	13	2	studies	study	NOUN
kk91fj26b0m	13	3	demonstrated	demonstrate	VERB
kk91fj26b0m	13	4	a	a	DET
kk91fj26b0m	13	5	gram	gram	NOUN
kk91fj26b0m	13	6	-	-	PUNCT
kk91fj26b0m	13	7	positive	positive	ADJ
kk91fj26b0m	13	8	selective	selective	ADJ
kk91fj26b0m	13	9	antibiotic	antibiotic	NOUN
kk91fj26b0m	13	10	was	be	AUX
kk91fj26b0m	13	11	able	able	ADJ
kk91fj26b0m	13	12	to	to	PART
kk91fj26b0m	13	13	be	be	AUX
kk91fj26b0m	13	14	used	use	VERB
kk91fj26b0m	13	15	to	to	PART
kk91fj26b0m	13	16	combat	combat	VERB
kk91fj26b0m	13	17	gram	gram	ADJ
kk91fj26b0m	13	18	-	-	PUNCT
kk91fj26b0m	13	19	negative	negative	ADJ
kk91fj26b0m	13	20	bacteria	bacteria	NOUN
kk91fj26b0m	13	21	when	when	SCONJ
kk91fj26b0m	13	22	in	in	ADP
kk91fj26b0m	13	23	combination	combination	NOUN
kk91fj26b0m	13	24	with	with	ADP
kk91fj26b0m	13	25	an	an	DET
kk91fj26b0m	13	26	adjuvant	adjuvant	NOUN
kk91fj26b0m	13	27	at	at	ADP
kk91fj26b0m	13	28	50	50	NUM
kk91fj26b0m	13	29	mg	mg	NOUN
kk91fj26b0m	13	30	/	/	SYM
kk91fj26b0m	13	31	kg	kg	NOUN
kk91fj26b0m	13	32	or	or	CCONJ
kk91fj26b0m	13	33	100	100	NUM
kk91fj26b0m	13	34	mg	mg	NOUN
kk91fj26b0m	13	35	/	/	SYM
kk91fj26b0m	13	36	kg	kg	PROPN
kk91fj26b0m	13	37	.	.	PUNCT
kk91fj26b0m	14	1	lastly	lastly	ADV
kk91fj26b0m	14	2	,	,	PUNCT
kk91fj26b0m	14	3	a	a	DET
kk91fj26b0m	14	4	chromosomally	chromosomally	ADV
kk91fj26b0m	14	5	colistin	colistin	PROPN
kk91fj26b0m	14	6	resistant	resistant	ADJ
kk91fj26b0m	14	7	a.	a.	NOUN
kk91fj26b0m	14	8	baumannii	baumannii	PROPN
kk91fj26b0m	14	9	strain	strain	NOUN
kk91fj26b0m	14	10	was	be	AUX
kk91fj26b0m	14	11	resensitized	resensitize	VERB
kk91fj26b0m	14	12	to	to	ADP
kk91fj26b0m	14	13	colistin	colistin	PROPN
kk91fj26b0m	14	14	with	with	ADP
kk91fj26b0m	14	15	an	an	DET
kk91fj26b0m	14	16	adjuvant	adjuvant	NOUN
kk91fj26b0m	14	17	,	,	PUNCT
kk91fj26b0m	14	18	where	where	SCONJ
kk91fj26b0m	14	19	the	the	DET
kk91fj26b0m	14	20	combinatorial	combinatorial	ADJ
kk91fj26b0m	14	21	injection	injection	NOUN
kk91fj26b0m	14	22	of	of	ADP
kk91fj26b0m	14	23	colistin	colistin	NOUN
kk91fj26b0m	14	24	-	-	PUNCT
kk91fj26b0m	14	25	adjuvant	adjuvant	NOUN
kk91fj26b0m	14	26	at	at	ADP
kk91fj26b0m	14	27	50	50	NUM
kk91fj26b0m	14	28	mg	mg	NOUN
kk91fj26b0m	14	29	/	/	SYM
kk91fj26b0m	14	30	kg	kg	NOUN
kk91fj26b0m	14	31	afforded	afford	VERB
kk91fj26b0m	14	32	over	over	ADP
kk91fj26b0m	14	33	40	40	NUM
kk91fj26b0m	14	34	%	%	NOUN
kk91fj26b0m	14	35	worm	worm	NOUN
kk91fj26b0m	14	36	survival	survival	NOUN
kk91fj26b0m	14	37	over	over	ADP
kk91fj26b0m	14	38	the	the	DET
kk91fj26b0m	14	39	course	course	NOUN
kk91fj26b0m	14	40	of	of	ADP
kk91fj26b0m	14	41	four	four	NUM
kk91fj26b0m	14	42	days	day	NOUN
kk91fj26b0m	14	43	versus	versus	ADP
kk91fj26b0m	14	44	no	no	DET
kk91fj26b0m	14	45	survival	survival	NOUN
kk91fj26b0m	14	46	for	for	ADP
kk91fj26b0m	14	47	untreated	untreated	ADJ
kk91fj26b0m	14	48	,	,	PUNCT
kk91fj26b0m	14	49	inoculated	inoculated	ADJ
kk91fj26b0m	14	50	worms	worm	NOUN
kk91fj26b0m	14	51	.	.	PUNCT